Background and aim: Due to the increased mortality and danger of bleeding, the presence of esophageal varices (EV) caused by portal hypertension is a serious concern in cirrhotic patients. 60-80% of newly diagnosed cirrhotic patients have EV, and 5-15% of big EV cases experience their first variceal bleeding within the first year. Our goal was to investigate the relationship between cardiac dysfunction and endoscopic indicators of portal hypertension in cirrhotic patients.Methods: 60 participants were included; 40 cirrhotic patients with oesophageal varices and 20 non-cirrhotic individuals with no evidence of portal hypertension in endoscopy (control group). Complete blood count, liver and kidney functions, Esophagogastroduodenoscopy, Electrocardiographic evaluation, and echocardiography were performed. Results:The QTc interval, the LA volume, LV mass index, E-wave deceleration time, atrial flow velocities, E/E′ ratio, and E/A ratio were significantly increased among cirrhotic patients compared to controls. However, only the LA volume was substantially higher and E/E′ ratio was considerably lower for patients with high-grade EV than those with low grades. ROC curve to discriminate between cirrhotic and noncirrhotic groups, the QTc interval, E-wave deceleration time, and E/A ratio had the highest accuracy 93.7%, 96.1%, and 84.2% respectively.Likewise, discriminating patients with high-grade EV from those with low ones, LA volume, E/È ratio, and QTc interval showed the highest accuracy at 75.6%, 70.9%, and 66.7% respectively with the sensitivity of 92.31, 100.0, and 76.92 respectively. Conclusion: Electrocardiographic and echocardiographicexaminations are valuable non-invasive procedures that could evaluate cardiac dysfunction in cirrhotic patients and could help predict EV .
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.